- Home
- JMSB vs AMRN Comparison
JMSB vs AMRN Comparison
Compare JMSB & AMRN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | JMSB | AMRN |
|---|---|---|
| Founded | 2005 | 1989 |
| Country | United States | Ireland |
| Employees | N/A | N/A |
| Industry | Major Banks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 295.1M | 304.7M |
| IPO Year | 2022 | 1998 |
Fundamental Metrics
Financial Performance| Metric | JMSB | AMRN |
|---|---|---|
| Price | $21.63 | $14.25 |
| Analyst Decision | Strong Buy | Strong Sell |
| Analyst Count | 3 | 1 |
| Target Price | ★ $23.00 | $12.00 |
| AVG Volume (30 Days) | 24.8K | ★ 57.8K |
| Earning Date | 04-29-2026 | 04-29-2026 |
| Dividend Yield | ★ 1.72% | N/A |
| EPS Growth | 24.17 | ★ 55.00 |
| EPS | ★ 0.43 | N/A |
| Revenue | N/A | ★ $181,104,000.00 |
| Revenue This Year | $17.09 | N/A |
| Revenue Next Year | $10.03 | $1.26 |
| P/E Ratio | $49.81 | ★ N/A |
| Revenue Growth | N/A | ★ 39.22 |
| 52 Week Low | $16.27 | $11.67 |
| 52 Week High | $22.10 | $20.90 |
Technical Indicators
Market Signals| Indicator | JMSB | AMRN |
|---|---|---|
| Relative Strength Index (RSI) | 56.47 | 46.19 |
| Support Level | $18.97 | $13.46 |
| Resistance Level | $21.97 | $14.49 |
| Average True Range (ATR) | 0.52 | 0.50 |
| MACD | 0.02 | -0.04 |
| Stochastic Oscillator | 71.04 | 42.14 |
Price Performance
Historical ComparisonAbout JMSB John Marshall Bancorp Inc.
John Marshall Bancorp Inc is a bank holding company. Through its banking subsidiary, it offers banking products and financial services to small to medium-sized businesses, professional corporations, non-profits, and individuals. The products and services offered by the company include commercial checking, savings, and money market accounts, certificates of deposit, treasury and cash management services, commercial and industrial loans, commercial real estate loans, residential and commercial construction and development loans, online banking, and mobile banking. The firm serves local businesses, professionals, individuals, and families throughout the Washington, D.C. metropolitan area.
About AMRN Amarin Corporation plc
Amarin Corp PLC is a pharmaceutical company. The company is focused on the commercialization and development of therapeutics to improve cardiovascular, or CV, health and reduce CV risk. Its commercialized product includes Vascepa. The company focuses on treatments to stop cardiovascular disease causing death, by providing patients, doctors and investors with reliable cardiovascular treatment options. Geographically, the company derives maximum revenue from United States.